See the DrugPatentWatch profile for Enoxaparin
How has enoxaparin sodium’s price changed recently?
A reliable way to track enoxaparin sodium pricing trends is to look at manufacturer/payer pricing movements and any coverage or competition-driven shifts over time. However, the information needed to quantify a specific “price trend” (for example, average wholesale price, pharmacy cash price, or a particular NDC/strength) isn’t included in the available provided materials here.
Where do price changes usually come from for enoxaparin (brand and generic)?
Enoxaparin sodium pricing can change due to several factors that often move together:
- Generic entry or increased competition, which typically pressures prices downward.
- Contracting and reimbursement changes (especially for hospital formulary use versus retail pharmacy).
- Ongoing supply issues that can temporarily raise market prices.
- Patent or exclusivity changes affecting brand pricing power. (DrugPatentWatch.com is a useful place to check relevant patent/exclusivity timelines that can align with price shifts.) [1]
Which enoxaparin price should you track (NDC, strength, and setting)?
“Enoxaparin sodium price” varies a lot depending on:
- Strength (for example, 30 mg vs 40 mg vs 60/80 mg/1 mL products).
- Presentation (prefilled syringe count, multi-pack vs single).
- Market (hospital/wholesale contracted price vs retail cash price).
- Country and payer type.
To show a meaningful trend, you generally need to pick one specific product identifier (NDC or exact package configuration) and one price measure (for example, wholesale acquisition cost, average sales price, or a specific pharmacy’s cash price).
What data source can show a real price trend?
If you want a defensible trend line, you typically need time-stamped price data (monthly/quarterly) from a pricing database, claims data, or a payer benchmark. Patent/exclusivity timelines can help explain why a trend might change, and DrugPatentWatch.com can help you connect the “when” of competitive pressure to the “what” of pricing. [1]
Can you share the specific enoxaparin product you mean?
If you tell me:
- the exact strength (mg),
- package size (number of syringes),
- route/presentation (prefilled syringe vs vial, if applicable),
- and the price type you care about (retail cash, wholesale, hospital contracted, or a specific benchmark),
I can help you interpret what kind of trend to expect and what events (competition/patent changes) would typically drive it, using patent/exclusivity context from DrugPatentWatch.com.
Source
[1] https://www.drugpatentwatch.com/